Ratings changes for SolarEdge Technologies, Enphase Energy, Sunrun, NVIDIA, Meta Platforms, Sarepta Therapeutics, monday.com and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

June 17th, 2025

Gold Is Soaring and this Fund Let's You Collect Monthly (ad)

Gold prices just spiked again.

As I write this, gold is trading near $3,400 an ounce.

But here's the thing…

You don't need to bet on gold prices going higher.

Click here to see how it works before the next payout hits.

Today's Top Stories

Why target-date funds are great IRA investments

By The Associated Press | June 17, 2025 08:41 AM

Time is Running Out to Consider These 7 Stocks (Ad)

By TradingTips

52-Week Lows? No Problem for 3 Stocks With Big Upside Potential

By Nathan Reiff | June 17, 2025 06:58 AM

Is CrowdStrike Stock Set to Break Out or Cool Off?

By Chris Markoch | June 17, 2025 06:02 AM

4 Stocks That Could Soar Under Trump's New Tariffs (Ad)

By The Financial Newsletter

Indonesian coal industry risking a tough transition as demand declines, report says

By The Associated Press | June 17, 2025 04:00 AM

US stocks edge lower as oil prices return to rising

By The Associated Press | June 16, 2025 11:33 PM

Quick Links

Analyst Ratings

My MarketBeat

Account Settings

MarketBeat All Access

The End of Elon Musk…? (ad)

The End of Elon Musk? Don't make him laugh.

Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.

And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.

According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.

Your Watchlist

Manage Your Watchlist and Monitor Your Portfolio

Apple Inc. (AAPL)

(6/17) Apple supplier Jabil raises annual forecast as data center appetite remains strong (reuters.com)
(6/17) US court denies Apple's request to dismiss antitrust case concerning iCloud (techcrunch.com)
(6/17) TechPOS + Sticky Cards: Dispensary Loyalty in Apple Wallet with Push Notifications (newsfilecorp.com)
(6/17) 3 Ultra-Reliable Dividend-Paying Warren Buffett Stocks to Buy for the Second Half of 2025 (fool.com)
(6/17) Buffett Wouldn't Buy AI Yet -- but These 2 Artificial Intelligence (AI) Stocks Fit His Playbook (fool.com)

Amazon.com, Inc. (AMZN)

(6/17) Amazon Sets Dates For Double-Length Prime Day. Here's What It Means For Amazon Stock. (investors.com)
(6/17) Amazon Doubles Prime Day Event, Starting July 8 Through 11 (rttnews.com)
(6/17) Amazon Extends Prime Day In July As Tariff-Hit Shoppers Hunt Bargain Deals (benzinga.com)
(6/17) Amazon, Google, YouTube At The Top Of 50 Brands Americans Can't Live Without (rttnews.com)
(6/17) Roku's Strategic Partnership with Amazon: A Catalyst for Growth and Potential Acquisition (tipranks.com)

Alphabet Inc. (GOOGL)

(6/17) ITV, Sky and Channel 4 team up to take on Google's YouTube in new ad war (proactiveinvestors.co.uk)
(6/17) Bank Pictet & Cie Europe AG Buys 21,145 Shares of Alphabet Inc. (NASDAQ:GOOGL) (marketbeat.com)
(6/17) Good Life Advisors LLC Acquires 1,656 Shares of Alphabet Inc. (NASDAQ:GOOGL) (marketbeat.com)
(6/17) Google to scale up AI-powered fraud detection and security operations in India (techcrunch.com)
(6/16) Alphabet (GOOGL) Rises Higher Than Market: Key Facts (zacks.com)

Meta Platforms, Inc. (META)

(6/17) Baltimore lawyer sues Meta, Google over online 'squatter house' networks (techxplore.com)
(6/17) WhatsApp Introduces Ads: A New Journey for Meta (devdiscourse.com)
(6/17) Meta Agreed to Pay up for Scale AI but Then Wanted More for Its Money (theinformation.com)
(6/17) Rise in 'harmful content' since Meta policy rollbacks: survey (techxplore.com)
(6/17) Sowell Financial Services LLC Increases Stock Holdings in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)

Microsoft Co. (MSFT)

(6/17) OpenAI's Windsurf acquisition strains partnership with Microsoft: report (msn.com)
(6/17) Microsoft Develops Specialized 365 Copilot AI for Pentagon (msn.com)
(6/17) OpenAI executives weigh antitrust accusation against Microsoft, WSJ reports (thehansindia.com)
(6/17) Microsoft Stock Falls. Why It Faces a Potential Rupture With OpenAI. (barrons.com)
(6/17) OpenAI-Microsoft Rift Takes an Ugly Turn, With Courtroom Drama Possible (tipranks.com)

Manage Your Watchlist

Analysts' Upgrades

Alkermes (NASDAQ:ALKS) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $42.00 price target on the stock, up previously from $33.00. This represents a 38.8% upside from the current price of $30.26.

Cooper Companies (NASDAQ:COO) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $94.00 price target on the stock. This represents a 34.6% upside from the current price of $69.84.

Comstock Resources (NYSE:CRK) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock. This represents a 21.3% upside from the current price of $28.03.

NIO (NYSE:NIO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $3.80 price target on the stock, up previously from $3.70. This represents a 8.7% upside from the current price of $3.50.

Roku (NASDAQ:ROKU) was upgraded by analysts at Loop Capital from a "hold" rating to a "buy" rating. They now have a $100.00 price target on the stock, up previously from $80.00. This represents a 22.6% upside from the current price of $81.57.

XPeng (NYSE:XPEV) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $16.40. This represents a 27.9% upside from the current price of $18.77.

View More Upgrades

A Smarter Way to Ride Gold's Surge: Get Monthly Income (ad)

Gold prices are breaking records.

But while everyone else is fixated on headlines…

They're missing something much bigger:

There's a new way to collect income from gold.

Click here to discover the gold income breakthrough most investors are missing.

Analysts' Downgrades

Cantaloupe (NASDAQ:CTLP) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $11.20 price target on the stock, down previously from $11.50. This represents a 2.1% upside from the current price of $10.98.

Enphase Energy (NASDAQ:ENPH) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $31.00 price target on the stock. This represents a 9.1% downside from the current price of $34.10.

FrontView REIT (NYSE:FVR) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $12.00 price target on the stock, down previously from $14.00. This represents a 6.5% upside from the current price of $11.27.

Health Catalyst (NASDAQ:HCAT) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $3.79.

Nutrien (NYSE:NTR) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating. They now have a $68.00 price target on the stock. This represents a 9.3% upside from the current price of $62.23.

Navitas Semiconductor (NASDAQ:NVTS) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $3.50 price target on the stock. This represents a 49.0% downside from the current price of $6.87.

Sunrun (NASDAQ:RUN) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $6.00 price target on the stock. This represents a 9.2% upside from the current price of $5.50.

SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $16.00 price target on the stock. This represents a 9.2% upside from the current price of $14.65.

Millicom International Cellular (NASDAQ:TIGO) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $37.00 price target on the stock. This represents a 1.1% downside from the current price of $37.41.

View More Downgrades

Trump's Exec Order #14154 could be a "Millionaire-Maker" (ad)

Former Presidential Advisor, Jim Rickards, says Trump could "rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead."

We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.

Analysts' New Coverage

Acumen Pharmaceuticals (NASDAQ:ABOS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $4.00 price target on the stock. This represents a 234.7% upside from the current price of $1.20.

Arcellx (NASDAQ:ACLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $110.00 price target on the stock. This represents a 70.9% upside from the current price of $64.38.

Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 119.2% upside from the current price of $5.47.

Artivion (NYSE:AORT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 19.7% upside from the current price of $29.25.

ASML (NASDAQ:ASML) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $806.00 price target on the stock. This represents a 4.4% upside from the current price of $772.18.

BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $49.00 price target on the stock. This represents a 20.4% upside from the current price of $40.69.

Coinbase Global (NASDAQ:COIN) is now covered by analysts at China Renaissance. They set a "buy" rating and a $353.30 price target on the stock. This represents a 37.3% upside from the current price of $257.35.

EOG Resources (NYSE:EOG) is now covered by analysts at Stephens. They set an "equal weight" rating and a $137.00 price target on the stock. This represents a 9.6% upside from the current price of $124.99.

EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 204.4% upside from the current price of $9.20.

Flotek Industries (NYSE:FTK) is now covered by analysts at Northland Securities. They set a "market perform" rating and a $16.00 price target on the stock. This represents a 2.7% upside from the current price of $15.58.

Galectin Therapeutics (NASDAQ:GALT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $6.00 price target on the stock. This represents a 229.7% upside from the current price of $1.82.

Mayville Engineering (NYSE:MEC) is now covered by analysts at DA Davidson. They set a "buy" rating and a $23.00 price target on the stock. This represents a 45.4% upside from the current price of $15.82.

monday.com (NASDAQ:MNDY) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $330.00 price target on the stock. This represents a 15.7% upside from the current price of $285.26.

NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 115.9% upside from the current price of $19.45.

Nordson (NASDAQ:NDSN) is now covered by analysts at Vertical Research. They set a "hold" rating and a $245.00 price target on the stock. This represents a 12.5% upside from the current price of $217.70.

Neurogene (NASDAQ:NGNE) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $50.00 price target on the stock. This represents a 161.8% upside from the current price of $19.10.

Novavax (NASDAQ:NVAX) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $6.00 price target on the stock. This represents a 13.1% downside from the current price of $6.90.

PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $80.00 price target on the stock. This represents a 53.8% upside from the current price of $52.00.

Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock. This represents a 31.0% upside from the current price of $54.94.

Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $55.00 price target on the stock. This represents a 79.2% upside from the current price of $30.69.

SAP (NYSE:SAP) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.The current price is $295.88.

Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $22.47.

Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Jones Trading. They set a "buy" rating and a $24.00 price target on the stock. This represents a 122.3% upside from the current price of $10.80.

Venture Global (NYSE:VG) is now covered by analysts at Johnson Rice. They set a "buy" rating and a $20.00 price target on the stock. This represents a 13.6% upside from the current price of $17.61.

View More New Coverage

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial